![]() |
Name |
1,2-Benzisothiazol-3-amine
|
Molecular Formula | C7H6N2S | |
IUPAC Name* |
1,2-benzothiazol-3-amine
|
|
SMILES |
C1=CC=C2C(=C1)C(=NS2)N
|
|
InChI |
InChI=1S/C7H6N2S/c8-7-5-3-1-2-4-6(5)10-9-7/h1-4H,(H2,8,9)
|
|
InChIKey |
WIJQCPIRWXSWQG-UHFFFAOYSA-N
|
|
Synonyms |
1,2-Benzisothiazol-3-amine; 23031-78-9; 1,2-benzothiazol-3-amine; benzo[d]isothiazol-3-amine; 3-Amino-1,2-benzisothiazole; MLS000081875; SMR000060378; 613262-33-2; aminobenzoisothiazole; EINECS 245-388-4; 3-aminobenzisothiazole; 3-amino-benzisothiazole; 3-iminobenzisothiazoline; 1,2-benzothiazol-3-ylamine; benzo[d]isothiazol-3-ylamine; cid_89966; SCHEMBL290849; 3-aminobenzo(2,1)isothiazole; CHEMBL1458786; SCHEMBL11654916; BDBM38954; DTXSID40177588; HMS1753B15; HMS2490B20; ZINC854665; AMY28840; MFCD00726295; AKOS001012886; AC-5045; CS-W019021; FS-2862; DB-025529; FT-0646047; EN300-188513; 031A789; A816516; AA-516/30012037; J-503796; Z56774438
|
|
CAS | 23031-78-9 | |
PubChem CID | 89966 | |
ChEMBL ID | CHEMBL1458786 |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 150.2 | ALogp: | 2.0 |
HBD: | 1 | HBA: | 3 |
Rotatable Bonds: | 0 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 67.2 | Aromatic Rings: | 2 |
Heavy Atoms: | 10 | QED Weighted: | 0.626 |
Caco-2 Permeability: | -4.813 | MDCK Permeability: | 0.00003920 |
Pgp-inhibitor: | 0 | Pgp-substrate: | 0.019 |
Human Intestinal Absorption (HIA): | 0.021 | 20% Bioavailability (F20%): | 0.066 |
30% Bioavailability (F30%): | 0.561 |
Blood-Brain-Barrier Penetration (BBB): | 0.997 | Plasma Protein Binding (PPB): | 95.84% |
Volume Distribution (VD): | 1.164 | Fu: | 8.09% |
CYP1A2-inhibitor: | 0.865 | CYP1A2-substrate: | 0.894 |
CYP2C19-inhibitor: | 0.256 | CYP2C19-substrate: | 0.47 |
CYP2C9-inhibitor: | 0.052 | CYP2C9-substrate: | 0.495 |
CYP2D6-inhibitor: | 0.962 | CYP2D6-substrate: | 0.884 |
CYP3A4-inhibitor: | 0.015 | CYP3A4-substrate: | 0.174 |
Clearance (CL): | 6.289 | Half-life (T1/2): | 0.757 |
hERG Blockers: | 0.046 | Human Hepatotoxicity (H-HT): | 0.963 |
Drug-inuced Liver Injury (DILI): | 0.756 | AMES Toxicity: | 0.823 |
Rat Oral Acute Toxicity: | 0.923 | Maximum Recommended Daily Dose: | 0.255 |
Skin Sensitization: | 0.824 | Carcinogencity: | 0.878 |
Eye Corrosion: | 0.898 | Eye Irritation: | 0.987 |
Respiratory Toxicity: | 0.967 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC000177 | ![]() |
0.400 | D0K1XK | ![]() |
0.362 | ||
ENC000675 | ![]() |
0.326 | D09ZIS | ![]() |
0.333 | ||
ENC000167 | ![]() |
0.326 | D0E6YQ | ![]() |
0.327 | ||
ENC000341 | ![]() |
0.326 | D0QS1U | ![]() |
0.327 | ||
ENC005757 | ![]() |
0.313 | D0D5GG | ![]() |
0.320 | ||
ENC002806 | ![]() |
0.313 | D06CTE | ![]() |
0.311 | ||
ENC000303 | ![]() |
0.311 | D09JUG | ![]() |
0.304 | ||
ENC001333 | ![]() |
0.311 | D00VUL | ![]() |
0.293 | ||
ENC001799 | ![]() |
0.310 | D05EJG | ![]() |
0.291 | ||
ENC001448 | ![]() |
0.308 | D07HBX | ![]() |
0.273 |